ArticleFrontiers in medicine2026
Correlation analysis between quantitative lung ultrasound parameters and pulmonary function in idiopathic pulmonary fibrosis: an observational study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease (ILD) with limited monitoring tools. Lung ultrasound (LUS) has emerged as a promising radiation-free alternative, but its clinical utility in IPF requires further validation. This study aimed to comprehensively evaluate the correlation between quantitative LUS parameters and established disease severity markers in IPF patients. Methods: An observational study was conducted in eligible IPF patients. Participants underwent comprehensive assessment including clinical questionnaires, pulmonary function tests, serum KL-6 measurement, high-resolution computed tomography (HRCT), and a standardized LUS protocol. Correlation and multiple linear regression analyses were performed to examine the relationships between LUS indices and conventional severity markers. Results: The analysis included 47 IPF patients stratified by DLCO% predicted (≥60% mild, <60% moderate-severe). The moderate-severe group showed significantly higher B-line counts, B-line scores, pleural scores, diaphragm thickness and lower diaphragm thickening fraction ( Conclusion: Quantitative LUS parameters show strong and consistent correlations with clinical, functional, serological, and radiographic markers of IPF severity. These findings support the potential utility of LUS as a comprehensive, non-invasive tool for multidimensional disease assessment in IPF patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.